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Objective: Chronic visceral pain (CVP) syndromes are persistently painful disorders with 
a remarkable lack of effective treatment options. This study aimed at evaluating the 
effects of different neuromodulation techniques in patients with CVP on cortical activity, 
through electreocephalography (EEG) and on pain perception, through clinical tests.
Design: A pilot crossover randomized controlled study.
settings: Out-patient.
subjects: Adults with CVP (>3 months).
Methods: Participants received four interventions in a randomized order: (1) transcranial 
pulsed current stimulation (tPCS) and active transcranial direct current stimulation (tDCS) 
combined, (2) tPCS alone, (3) tDCS alone, and (4) sham condition. Resting state quan-
titative electroencephalography (qEEG) and pain assessments were performed before 
and after each intervention. Results were compared with a cohort of 47 healthy controls.
results: We enrolled six patients with CVP for a total of 21 visits completed. Compared 
with healthy participants, patients with CVP showed altered cortical activity characterized 
by increased power in theta, alpha and beta bands, and a significant reduction in the 
alpha/beta ratio. Regarding tES, the combination of tDCS with tPCS had no effect on 
power in any of the bandwidths, nor brain regions. Comparing tPCS with tDCS alone, we 
found that tPCS induced higher increase in power within the theta and alpha bandwidths.
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conclusion: This study confirms that patients with CVP present abnormal EEG-indexed 
cortical activity compared with healthy controls. Moreover, we showed that combining 
two types of neurostimulation techniques had no effect, whereas the two interventions, 
when applied individually, have different neural signatures.
Keywords: chronic visceral pain, pain, transcranial direct current stimulation, transcranial pulsed current 
stimulation, non-invasive brain stimulation, electroencephalogram
inTrODUcTiOn
Visceral pain results from nociceptor activation in thoracic, 
pelvic, or abdominal visceral organs (1). While acute pain has 
the vital role of preventing tissue damage, maladaptive processes 
may convert it into chronic (2), leading to chronic visceral pain 
(CVP), a condition featured by several maladaptive neural 
changes, one of them being central sensitization (3). The neural 
mechanisms of central sensitization in chronic neuropathic con-
ditions are partially understood (4, 5). For instance, Simis et al. 
showed that patients with pelvic pain had significantly lower 
levels of N-acetylaspartate (NAA) and creatinophosphocreatine 
(Cr), reflecting loss of neuronal integrity in the primary motor 
cortex compared with healthy participants. This evidence also 
highlights the process of maladaptive plasticity in neural circuits 
involved in pain modulation (6). Notwithstanding, there is lim-
ited evidence showing neural correlates of pain-induced central 
sensitization in CVP. In addition, the investigation of cortical 
oscillation patterns by means of electroencephalography (EEG) 
is still at its infancy in patients with CVP.
This paucity of knowledge regarding neural correlates of CVP 
further undermines treatment interventions. CVP is character-
ized by high level of disability and discomfort (7–9) which affect 
patients’ quality of life and represent an important clinical prob-
lem and socioeconomic burden for societies (9–13). The lack of 
effective treatments, in turn, favors the excessive use of opioids 
(and their side effects), potentially leading to abuse (14, 15). 
Therefore, it is essential to develop new therapeutic options for 
CVP. Preliminary studies have shown that transcranial electrical 
stimulation (tES), in particular transcranial direct current stimu-
lation (tDCS), may help managing pain. tDCS, in fact, by influ-
encing neuronal cortical activity (16), has been proven capable 
of inducing clinical improvements in several chronic conditions 
(17, 18), such as fibromyalgia (19), abdominal (20), and refractory 
pelvic (21) pain. Recently, another tES technique, namely, tran-
scranial pulsed current stimulation (tPCS) has gained increasing 
attention in experimental settings (22–24). tPCS, using randomly 
pulsed alternating current within a determined frequency range, 
is thought to reach cortical and subcortical brain regions such 
as the midbrain, pons, thalamus, insula, and the hypothalamus 
(25). Therefore, also tPCS, thanks to its mechanisms of action, 
could represent a promising tool for the treatment of pain, as it is 
potentially able to influence deeper structures involved in chronic 
pain.
In this scenario, we conducted a pilot study with a twofold 
aim: first, we wanted to assess baseline cortical activity of CVP 
patients; results are compared with those obtained by a normative 
sample of neurological healthy participants, published elsewhere 
(26). Second, we sought to assess the effects of two tES interven-
tions, on cortical activity by means of EEG. We also provided 




The inclusion criteria were as follows: (1) age between 18 and 
65; (2) history of visceral pain for at least 3 months; (3) an aver-
age pain ≥4 in the past 3  months, as measured by the visual 
analog scale (VAS); (4) no history of neurologic or psychiatric 
conditions and no current unstable medical conditions; (5) no 
contraindications to tES; and (6) no current pregnancy. The study 
was approved by the Institutional Review Board of Spaulding 
Rehabilitation Hospital and performed in accordance with the 
Declaration of Helsinki. Healthy subjects’ cohort data have been 
published elsewhere (26).
study Design
We conducted a pilot randomized, double-blind, sham-controlled 
crossover trial. Participants received the following four interven-
tions in a randomized order separated by a minimum of 5 days: 
(1) active tPCS/active tDCS; (2) active tPCS/sham tDCS; (3) 
sham tPCS/active tDCS, and (4) sham tPCS/sham tDCS. Each 
stimulation condition was preceded and followed by EEG and 
clinical assessments.
Transcranial Direct current stimulation
Transcranial direct current stimulation was delivered with the 
anode electrode positioned over the left primary motor cortex 
(M1) and the cathode electrode over the contralateral right supra 
orbital region (Soterix Medical, NY, USA). Stimulation param-
eters were as follows: 20 min at 2 mA, 30-s fade-in and fade-out.
Transcranial Pulsed current stimulation
We used an investigational, custom-made, battery-powered and 
high-frequency tPCS device (Lab 8Tron AG) that delivered a 
quadratic biphasic alternating current using periauricular ear-
clip electrodes. Stimulation parameters for tPCS were as follows: 
20 min of stimulation at a fixed current intensity of 2 mA and 
a random noise frequency of 6–10 Hz [as previously described 
(23)]. For sham conditions (both tDCS and tPCS), stimulation 
parameters were the same, but the device turned off automatically 
after 30 s (27).
TaBle 1 | Demographical and clinical data of the patients.
iD age/gender Diagnosis race level of education Di (months) Pain medication
1 51/F CP Caucasian College 36 Fentanyla, Oxycodonea
2 24/M CP Caucasian College 5 Oxycodonea, Dilaudida
3* 36/F CP Caucasian College 24 Paracetamol, Ibuprophen
4 33/M CP Caucasian Bachelor 108 Oxycotina, Oxycodonea
5 31/F CP African-American Bachelor 61 Lidocaine, Ibuprophen, Hydromorphonea
6 44/F CP Caucasian College 61 Tapentadola
aOpioids.
*This patient underwent only one visit.
CP, chronic pancreatitis; DI, duration of illness; F, female; ID, patients’ identification number; M, male.
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Quantitative electroencephalography 
(qeeg) recording, analysis of Power  
and interhemispheric coherence
We used a 64-channel, high-density Electrical Geodesic Inco-
rporated EEG device (Electrical Geodesics, OR, USA). EEG was 
recorded for 6 min eyes-closed. Data were sampled at 250 Hz, 
amplified and filtered using a bandpass of 0.1–70 Hz. For offline 
analysis, we used a low-pass filter of 40 Hz and high-pass of 1 Hz, 
followed by manual artifact detection and rejection by a blind 
assessor. Power and coherence were calculated using EEGLab (28) 
and MATLAB (MATLAB R2012a; The MathWorks Inc., Natick, 
MA, USA). Fast Fourier transformation (averaged windows of 5 s 
with 50% overlap) was used to calculate power (μV2) for the EEG 
bands theta (4–8 Hz), alpha (8–13 Hz) and beta (13–30 Hz), and 
the sub-bands low-alpha (8–10 Hz) and high-alpha (10–13 Hz). 
We also determined the alpha/beta power ratio. The signal from 
adjacent electrodes was averaged to represent frontal, central, 
parietal, temporal, and occipital areas.
We calculated interhemispheric coherence for these bands 
and sub-bands using two different electrode pairs: E19–E56 and 
E14–E57, located in the frontotemporal junction and including 
their reciprocal location in the contralateral hemisphere. Welch’s 
averaged modified periodogram method was used to find the esti-
mated coherence of signal x and y, representing each electrode site.
clinical assessments
Visual analog scale for pain, anxiety, depression, stress, and 
sleepiness was collected. Von Frey Hair Assessment (North Coast 
Medical, Inc., Morgan Hill, CA, USA), comprised of monofila-
ments (0.008–300 g) was used to determine subjects’ perception 
threshold. This assessment was performed on the patient’s most 
painful region and over the ipsilateral hand to serve as a control. 
Pressure pain threshold (PPT) was also performed to measure sub-
jects’ pain threshold (Commander Algometer, JTECH Medical, 
UT, USA). PPT was measured over the thenar eminence of both 
hands, namely, both ipsi- and contralateral to the most painful 
body area. For the evaluation of conditioned pain modulation 
(CPM), the same test applied for the PPT (test-stimulus) was 
repeated while the subject’s contralateral hand was immersed in 
cold water for 30 s (conditioned-stimulus).
statistical analyses
To compare neurophysiological and behavioral data of healthy 
controls (HCs) with that of CVP patients, we used baseline data of 
the first visit for each participant. Continuous variables (i.e., age 
and years of education) were compared using a t-test, while gender 
was analyzed using a χ2 test. Regarding EEG, baseline rhythms for 
each frequency band were compared between patients and HC 
(26), using a Mann–Whitney U test.
For patients only, Kruskal–Wallis test was used to evaluate 
the effects of stimulation on power and coherence variables 
(difference between pre- and post-stimulation values) with 
tES (tPCS/tDCS, tPCS, tDCS, and Sham) as independent fixed 
variable. Mann–Whitney tests were applied for post hoc com-
parisons. For each clinical assessment, a Friedman’s ANOVA 
was performed, with tES (tPCS/tDCS, tPCS, tDCS, and Sham) 
as the main factor.
resUlTs
Six patients (2 males and 4 females) were included in the present 
study (see Table 1 for demographic and clinical data) for a total 
of 21 visits completed (5 patients completed the tPCS/tDCS 
session, 5 completed the tPCS session, 6 completed the tDCS 
session, and 5 completed the sham session). One patient drop 
out after the first visit (tDCS session) due to scheduling issues.
Baseline characteristics of Patients 
compared with hc
Chronic visceral pain patients and HC were similar for age 
(t = 0.885; p = 0.432), gender (χ2 = 0.24; p = 0.622), and level 
of education (t = 2.47; p = 0.122). At baseline, CVP patients had 
significantly more power in theta (p < 0.001), alpha (p < 0.0001), 
low-alpha (p < 0.001), and beta (p < 0.001) bandwidths, compared 
with HC. On the other hand, alpha/beta ratio was significantly 
reduced in patients with CVP (p < 0.001) (Table 2).
eeg Power analysis in Patients
tES Effect
There were no differences in the baseline power spectrum in 
the frontal, central, parietal, temporal, or occipital brain regions 
(all ps > 0.05). After tES, there was a significant effect over all 
areas combined (i.e., global) for the theta bandwidth (p < 0.001), 
for the low-alpha (p = 0.016), high-alpha (p = 0.027) bandwidths, 
and for alpha/beta ratio (p < 0.001); see Figure 1. We also found 
a tES effect over the central and the parietal regions for the alpha/
beta ratio (p = 0.037 and p = 0.028, respectively) and over the 
occipital region for the theta bandwidth (p = 0.002). No other 
FigUre 1 | Differences in absolute power between groups. Mean differences (pre- versus post-intervention) of power for theta and low-alpha bandwidths. The bars 
represent the standard error. * Significant difference between groups.
TaBle 2 | Power spectra.
group Theta (μV2) alpha (μV2) low alpha (μV2) high alpha (μV2) Beta (μV2) ratio α/β
CVP 0.10 ± 0.08* 0.19 ± 0.28* 0.29 ± 0.56* 0.13 ± 0.10 0.016 ± 0.01* 12.83 ± 5.9
HC 0.05 ± 0.08 0.15 ± 0.17 0.19 ± 0.23 0.12 ± 0.19 0.012 ± 0.01 18.6 ± 20.1*
Mean and SD of the baseline power spectrum for the different bandwidths in healthy controls (HC) and patients with chronic visceral pain (CVP).
*Significant difference between HC and CVP.
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effect was significant. Figure 2 represents the different topomaps 
of a representative patient (patient 1).
Post Hoc Analysis
As shown in Figure 1, combined tPCS with tDCS was not dif-
ferent as compared with sham for any of the frequency bands or 
brain regions (all ps > 0.05). In contrast to tDCS, tPCS induced 
significantly higher increase in power, in theta (p < 0.001) and 
low-alpha (p = 0.004) bandwidths, as well as for the alpha/beta 
ratio (p = 0.011) for global. In addition, tPCS induced a signifi-
cantly higher increase in theta power over the occipital region, as 
compared with tDCS (p < 0.001).
Transcranial direct current stimulation induced higher 
reduction in power of theta (p = 0.002) and low-alpha (p = 0.01) 
bandwidths as compared with sham, as well as a reduction of 
alpha/beta ratio (p < 0.001) for global. In addition, tDCS induced 
a reduction of the alpha/beta ratio over the frontal region, but this 
decrease was significantly less important than sham (p = 0.023).
Transcranial pulsed current stimulation induced a decrease in 
power in the high-alpha bandwidth for global (p = 0.033) as com-
pared with sham. Despite a significant group effect for alpha/beta 
ratio over the parietal region, none of the post hoc tests reached 
the significance level.
coherence
No group effect for any bandwidths or brain regions was found 
(all ps > 0.05).
Individual power and coherence data can be found in 
Supplementary Material.
clinical assessments
No differences were found in either depression VAS (χ2 = 3.86; 
p =  0.27), anxiety VAS (χ2:1.5, p =  0.68), stress VAS (χ2:4.87, 
p =  0.18), sleepiness VAS (χ2 =  55.7, p =  0.12), or pain VAS 
(χ2 = 5.87, p = 0.12). No significant effect was found for Von Frey 
assessment over the painful- (χ2 = 6.6, p = 0.08), nor over the 
non-painful (thenar) region (χ2 = 2.6, p = 0.46) region.
Similarly, no significant differences were found for PPT 
(χ2 = 0.4; p = 0.94) or CPM (χ2 = 3.5; p = 0.32).
Individual clinical data can be found in Supplementary 
Material.
DiscUssiOn
The present study yielded interesting findings: (1) patients with 
CVP display abnormal neural activity compared with healthy 
controls, as indexed by qEEG; (2) EEG captured cortical changes 
following tES, similar to what was observed in healthy controls, 
while no clinical improvement was noticed; (3) combining tDCS 
with tPCS does not induce specific changes in neural activity; 
(4) tDCS and tPCS have different neural signature.
So far, only few studies have investigated the neurophysiological 
patterns of patients with CVP. For instance, EEG measures in 
FigUre 2 | Topoplots showing the topographic distribution of the different bandwidths for a representative individual before and after each intervention. Red areas 
represent higher activity, while blue areas represent lower activity.
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patients with chronic pancreatitis show an increase in power in 
the theta and alpha frequency bands as well (29). Present find-
ings substantiate this altered cortical activity in patients with 
CVP. Our results, in fact, show an increased power in different 
frequencies bands (i.e., theta, low alpha, and beta) and a decrease 
in low versus high frequencies ratio, as compared with healthy 
participants (26). Therefore, this feature seems to represent a 
reproducible pattern in patients with chronic pain, as pointed out 
by a recent systematic review (30).
Baseline cortical activity could serve as a biomarker for treat-
ment effects and as a predictor of response when using tES and 
other neuromodulatory techniques. As seen in patients with spinal 
cord injury and chronic pain, increased theta power at baseline 
was associated with greater response to analgesic treatment; in 
this case, hypnosis (31). We also noticed that the alpha/beta 
ratio was significantly reduced in patients with CVP, compared 
with healthy participants (26). Even though our sample size is 
small to define a neurophysiological biomarker that serves as a 
predictor of response to tES, EEG may represent a valuable tool 
for this purpose in chronic pain (29, 32, 33). For instance, it has 
been shown that peak alpha frequency may represent valuable 
biomarker for chronic pain, as this measure is not only greatly 
decreased in patients, compared with healthy participants, but it 
is also correlated with the duration of pain (29). In this context, 
this pilot study provides the initial data to support further stud-
ies investigating changes in brain oscillations and maladaptive 
plasticity in patients with CVP.
An important mechanism that deserves further investigation 
in the context of these results is the interaction between pain, 
immune system and electrical stimulation. It has been discussed 
before that pain may trigger also immune mechanisms in a 
two-way brain response to injury (34) and electrical stimulation 
may modulate this interaction (35). This relationship between 
immune system and pain may also be used to find useful bio-
markers and responders. For instance, the relationship between 
gene expression and pain has been demonstrated in mice (36). 
Specifically, it has been shown that cholecystokinin is implicated 
in the modulation of pain sensitivity and the development of 
neuropathic pain in mice and, more interestingly, when the 
cholecystokinin receptor gene is removed, the pain sensitivity is 
reduced and the development of hyperalgesia is abolished (37). 
In this context, a combination of electrophysiology and immune 
system gene expression study could open new doors and new 
treatments options in the field of chronic pain.
While no changes were observed clinically, neurophysi-
ologically, the combination of tDCS with tPCS did not lead to 
any changes in brain activity, while the application of the two 
techniques separately induced different cortical modifications, as 
already demonstrated (23, 24, 38, 39). Therefore, it is becoming 
increasingly apparent that the effects of tDCS and tPCS are not 
mediated by the same neurophysiological mechanisms (40). 
By reaching deeper structures, it seems feasible that tPCS could 
stimulate bottom–up connectivity trough thalamo-cortical cir-
cuits (40). On the other hand, tDCS seems to target a top–down 
cortico-thalamic pathway (41) and increases cortical excit-
ability under the stimulating electrodes and associated cortical 
networks (38). It is possible that tPCS and tDCS, when applied 
simultaneously, would eliminate their respective effects on brain 
activity. This important result underscores the need of careful 
consideration before associating different tES techniques.
Considering each technique individually, tPCS has shown 
promising and reproducible results as a neuromodulatory tool 
given the reported effects on coherence and power (22, 23, 40). 
In particular, in healthy volunteers, 6–10  Hz tPCS seems to 
modulate brain oscillation within the spectrum contained in 
these frequencies (i.e., high theta and low alpha). While for tDCS, 
an increased power has been observed in the high beta bandwidth 
over temporal and parietal regions, as compared with sham.
Our results showed that tPCS induced a higher increase in 
power within these two specific frequency bands compared with 
tDCS. We also identified a decrease in power for high-alpha 
bandwidth after tPCS and a decrease in power for theta and 
low-alpha bandwidths after tDCS, as compared with sham. This 
reduction in EEG power may represent a cortical modulation 
reducing a putative pathological over-excitability in patients suf-
fering from chronic forms of pain. In fact, baseline EEG power of 
the main frequency bands is increased in CVP as compared with 
HC, suggesting a pathological over-activity in patients, especially 
over the sensorimotor cortex (i.e., central region). Therefore, the 
decrease here found can be interpreted as a normalization of the 
cortical oscillations, leading to a pattern more similar to healthy 
conditions.
No clinical changes were observed after tDCS, tPCS, or both 
interventions combined. Evidence shows that repeated tES ses-
sions, and tDCS in particular, are required to induce long-lasting 
and significant clinical effects in psychiatric (42), motor (43), and 
pain conditions (44). Particularly, a significant decrease in chronic 
abdominal pain was registered after 5 days of anodal tDCS over 
the left motor cortex and persisted 1 week later (20). Similarly, 
a modest reduction of pain was reported by a small group of 
patients after two tDCS sessions (21). Moreover, a mean pain 
response of 58% compared with sham was registered after 5 days 
of anodal stimulation of the left motor cortex in neuropathic 
pain (45). It is hypothesized that recurring stimulation sessions 
are needed to produce perceptible and lasting clinical effects due 
to mechanisms resembling long-term potentiation (LTP) and 
long-term depression (LTD). Therefore, it is quite possible that 
a single-stimulation session was not sufficient to induce clinical 
effects in this experiment. Furthermore, the EEG montage and 
recording, often taking up to 20  min, was performed after the 
end of the stimulation. This represents a gap between the end of 
stimulation and clinical assessments, potentially allowing for any 
measurable effect to fade out by the time of collection.
Present findings, although preliminary, appear promising 
regarding the potentiality of tES techniques in modulating patho-
logical cortical activity in CVP. Notwithstanding, they should be 
considered cautiously. When studying patients suffering from 
chronic pain, the effect of medications on spontaneous brain 
oscillations should be considered. In the present study, all patients 
but one were under one or more opioids drugs (see Table  1). 
Opioid-induced slowing of the EEG has been demonstrated 
with different morphine derivatives such as fentanyl (46) and 
oxycodone (47) under controlled infusions, while tramadol an 
opioid-like agent favors fast EEG power spectrum responses (48), 
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including spikes generation. Still, prolonged use of oral or topic 
administration of these agents might induce modulation of 
spontaneous brain activity measured on scalp EEG, especially, 
shifting the background rhythm toward the low frequencies of 
the spectrum. For the results presented here, medication can be 
considered a confounding or interacting variable which deserves 
better control in future studies. However, as every patient received 
the four conditions (except for one), we can consider that pain 
medication influenced brain activity identically for the four types 
of tES.
Regarding the sham intervention, an important placebo 
component was identified (i.e., increase in theta and alpha and 
a decrease in beta bandwidths following the sham intervention). 
This could be interpreted in two different ways: (1) the observed 
increase in theta and alpha power and decrease in high-frequency 
bands could be related to relaxation. A similar pattern has been 
observed, for instance, under meditation (49–51). Here, active 
tES could enhance patients’ attention and therefore does not 
lead to an increase in drowsiness related rhythms. Therefore, 
the observed modification after the sham stimulation could be 
due to the other active conditions that blocked the occurrence of 
these modifications. (2) In this population of patients, the placebo 
effect and expectations are important components to take into 
account placebo effect and is often observed in patients with 
chronic pain (52) and also after electrical stimulation (53). This 
placebo effect could also partially explain our findings following 
the sham stimulation. Another important limitation to consider 
is that this study was a pilot exploratory study, and thus the lack 
of significant results in some of the analyses may simply indicate 
lack of power for that analysis. The goal was to inform feasibility 
and also provide effect estimates and discuss preliminary findings 
to design further studies.
conclusion and Future Directions
With respect to tES techniques, our preliminary data suggest 
that the combination of tDCS with tPCS, applied simultane-
ously, does not lead to improvements in cortical oscillations, 
similarly to what has been observed in healthy population (26). 
We also highlighted that tDCS and tPCS influence brain activity 
differently, and therefore may be underlined by different neural 
mechanisms as previously shown (26, 40). While there are a 
limited amount of data on the neurophysiological reorganization 
in patients with CVP, our results could help designing future trials 
using tES as an intervention and neurophysiological assessment 
to evaluate its effects. EEG could represent a suitable biomarker 
to characterize neural states of chronic pain and to capture the 
immediate effects of tES (single or short-term protocol). In this 
scenario, EEG could further be used as a predictor of response 
(i.e., to differentiate treatment responders from non-responders 
based on their neural signature), and to better understand the 
neurophysiological mechanisms of tES on pain relief. The combi-
nation of clinical assessments and EEG may become a useful tool 
to tailor customized treatment options and improve the efficacy 
of tES in alleviating pain.
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